HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An analysis of the efficacy of treatments for bipolar depression.

Abstract
Individuals with bipolar disorder are euthymic approximately half of the time, but recurring mood episodes are common, and time spent ill is predominated by depressive symptoms. Despite the prevalence of depression in bipolar disorder, evidence suggests that antidepressants are not likely to benefit most patients. Lithium, long considered a first-line treatment for bipolar disorder, is not the most effective agent for preventing bipolar depression. This article reviews multiple pharmacologic options that should be considered by clinicians treating bipolar disorder in both acute and maintenance phases.
AuthorsAndrew A Nierenberg
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 69 Suppl 5 Pg. 4-8 ( 2008) ISSN: 1555-2101 [Electronic] United States
PMID19265634 (Publication Type: Journal Article, Review)
CopyrightCopyright 2008 Physicians Postgraduate Press, Inc.
Chemical References
  • Anticonvulsants
  • Antidepressive Agents
  • Antimanic Agents
  • Antipsychotic Agents
  • Dibenzothiazepines
  • Fluoxetine
  • Benzodiazepines
  • Lithium Carbonate
  • Quetiapine Fumarate
  • Olanzapine
Topics
  • Acute Disease
  • Adverse Drug Reaction Reporting Systems
  • Affect (drug effects)
  • Anticonvulsants (adverse effects, therapeutic use)
  • Antidepressive Agents (adverse effects, therapeutic use)
  • Antimanic Agents (adverse effects, therapeutic use)
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Benzodiazepines (adverse effects, therapeutic use)
  • Bipolar Disorder (diagnosis, drug therapy, psychology)
  • Diagnosis, Differential
  • Dibenzothiazepines (adverse effects, therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Fluoxetine (adverse effects, therapeutic use)
  • Humans
  • Lithium Carbonate (adverse effects, therapeutic use)
  • Long-Term Care
  • Olanzapine
  • Quetiapine Fumarate
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: